Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer, August 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 308 articles:
HTML format


 

Single Articles

  1. LONG Y, Yu T, Shi D, Song L, et al
    T7-assisted special rolling circular amplification platform for point-of-care cervical cancer screening.
    Biosens Bioelectron. 2025;288:117831.
    PubMed    
    Abstract available

  2. WANG S, Wang J, Wang K
    LncRNA PCED1B-AS1 facilitates cervical cancer progression via targeting miR-361-3p.
    Nucleosides Nucleotides Nucleic Acids. 2025.
    PubMed    
    Abstract available

  3. NIU J, Sasidharan S
    Development of a Mitochondrial Permeability Transition-Driven Necrosis-Related Prognostic Signature in Cervical Cancer: Integrating Bulk Transcriptomic and Single-Cell Data.
    Cancer Med. 2025;14:e71094.
    PubMed    
    Abstract available

  4. JIAO L, Gao Y
    miR-21-5p inhibitor enhances the radiosensitivity of human cervical cancer cells via blocking CPEB3-mediated CDK1/cyclin B pathway.
    Biochem Biophys Rep. 2025;43:102177.
    PubMed    
    Abstract available

  5. LAHDHIRI A, Benzina B, Ennaifer E, Tounsi H, et al
    HPV DNA screening and vaccination strategies in Tunisia.
    Sci Rep. 2025;15:27916.
    PubMed    
    Abstract available

  6. SADEGHI Z, Aboofazeli A, Sarrafzadeh S, Tayebi N, et al
    Investigating the link between HPV genotypes and cervical abnormality incidence in women with HPV infections: insights from a leading referral centre.
    Virol J. 2025;22:264.
    PubMed    
    Abstract available

  7. KITAJIMA K
    Updates and advances for gynecologic imaging.
    J Obstet Gynaecol Res. 2025;51:e70025.
    PubMed    
    Abstract available

  8. GUO A, Yu Y, Guo Q, Zhang E, et al
    Potential Role of PARVB in Macrophage-Mediated Immunosuppression and Cervical Cancer Progression.
    Lab Invest. 2025 Jul 29:104223. doi: 10.1016/j.labinv.2025.104223.
    PubMed    
    Abstract available

  9. ARAI RJ, da Costa TR, Bonadio RC, Ferreira S, et al
    Exploratory unsupervised machine learning of angiogenesis biomarkers in a phase II advanced cervical cancer trial of radiochemotherapy with or without neoadjuvant chemotherapy.
    Clinics (Sao Paulo). 2025;80:100723.
    PubMed    
    Abstract available

  10. MARTINEZ-CASTILLO MA, Cueto MAH, Taniguchi-Ponciano K, Salcedo M, et al
    RET could act as suppressor tumor gene in cervical cancer cells.
    Gac Med Mex. 2025;161:132-139.
    PubMed    
    Abstract available

  11. MARTIN TM, Castro CC, Glickman A, Carreras N, et al
    Sentinel lymph node biopsy versus pelvic lymphadenectomy for early-stage cervical cancer: a retrospective institutional review.
    Arch Gynecol Obstet. 2025 Jul 31. doi: 10.1007/s00404-025-08134.
    PubMed    
    Abstract available

  12. WHITLEY S, Hawkins RL, Davies JC, Cao J, et al
    Acceptability of Self-Sampling for Cervical Screening in Ethnically Diverse Groups in Northwest England: A Focus Group Study.
    Health Expect. 2025;28:e70338.
    PubMed    
    Abstract available

  13. RZYMSKA A, Kycler W, Muszynska M, Rzymski P, et al
    Limited confidence in cervical cancer screening - unusually increased carcinoembryonic antigen expression resulting in the rapid development of cervical intraepithelial neoplasia grade 2.
    Arch Med Sci. 2025;21:1073-1076.
    PubMed    


  14. KERNELL CG, Kassick M, George JM, Anakwenze CP, et al
    Assessing delays in accessing and completing radiotherapy for cervical cancer treatment: A multicenter survey of oncology providers in go further-funded countries in Sub-Saharan Africa.
    Gynecol Oncol Rep. 2025;60:101810.
    PubMed    
    Abstract available

  15. KAWASAKI R, Kukimoto I, Nishio E, Otani S, et al
    Distinct cervical microbiome and metabolite profiles before and after menopause: implications for cervical cancer progression.
    Front Cell Infect Microbiol. 2025;15:1589277.
    PubMed    
    Abstract available

  16. KIRAN S, Akbolat M
    Perceived barriers and facilitators in access to breast and cervical cancer screening: a qualitative exploration among women in Trabzon, Turkey.
    J Health Organ Manag. 2025 Aug 1:1-17. doi: 10.1108/JHOM-12-2024-0503.
    PubMed    
    Abstract available

  17. LIU J, Zhong M, Yang K, Wang J, et al
    Proteomics analysis reveals FEN1 as a promising therapeutic target against small cell neuroendocrine carcinoma of the cervix.
    Sci Rep. 2025;15:27827.
    PubMed    
    Abstract available

  18. LIU M, Luo Y, Song X, Mo R, et al
    Caerin 1.1/1.9 interfere KHDRBS1-DDX5 regulatory axis to induce IL-18 mediated pyroptosis in a HeLa cell tumour model.
    Sci Rep. 2025;15:27866.
    PubMed    
    Abstract available

  19. IWAMI M, Bouaddi O, Razai MS, Mansour R, et al
    Drivers of human papillomavirus vaccine uptake in migrant populations and interventions to improve coverage: a systematic review and meta-analysis.
    Lancet Public Health. 2025;10:e693-e711.
    PubMed    
    Abstract available

  20. SHARMA S, Mishra A, Pandey P, Verma M, et al
    Emerging Protein Therapeutics as a Strategy for Cervical Cancer Treatment.
    Curr Pharm Biotechnol. 2025 Jul 25. doi: 10.2174/0113892010397753250704105423.
    PubMed    
    Abstract available

  21. ELLIS LB, Bowden SJ, Lyons D, Kyrgiou M, et al
    SIP 7: Progress in Cervical Cancer Prevention in the UK (2025 Second Edition).
    BJOG. 2025 Jul 30. doi: 10.1111/1471-0528.18262.
    PubMed    
    Abstract available

  22. ZHANG S, Shen X, Cui H
    Regulation of prognosis and tumor progression in cervical cancer by circ_0005728.
    Nucleosides Nucleotides Nucleic Acids. 2025.
    PubMed    
    Abstract available

  23. OKOLIE EA, Beek K, Patel B, Ndikom CM, et al
    Cervical Cancer Prevention and Control in Nigeria: Mapping and review of policies.
    Health Policy Plan. 2025 Jul 30:czaf049. doi: 10.1093.
    PubMed    
    Abstract available

  24. SCHICHL K, Doorbar J
    Regulation and Deregulation of Viral Gene Expression During High-Risk HPV Infection.
    Viruses. 2025;17:937.
    PubMed    
    Abstract available

  25. LI J, Asat R, Li W, Parhat P, et al
    Molecular Target Identification of Gossypol Against Cervical Cancer Based on Target Fishing Technology.
    Pharmaceutics. 2025;17:861.
    PubMed    
    Abstract available

  26. GIANNELLA L, Grelloni C, Natalini L, Sartini G, et al
    Molecular Features of HPV-Independent Cervical Cancers.
    Pathogens. 2025;14:668.
    PubMed    
    Abstract available

  27. NITTAYABOON K, Molika P, Bissanum R, Leetanaporn K, et al
    Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Modulate Chemoradiotherapy Response in Cervical Cancer Spheroids.
    Pharmaceuticals (Basel). 2025;18:1050.
    PubMed    
    Abstract available

  28. LEBLANC ME, Line EC, Potter J, Goldman RE, et al
    Advancing equity in cervical cancer screening for sexual and gender minoritized people assigned female at birth (SGM AFAB) in the United States: recommendations from healthcare equity leaders.
    Reprod Health. 2025;22:135.
    PubMed    
    Abstract available

  29. SULTANOV M, de Bock GH, Koot JAR, de Zeeuw J, et al
    High-risk human papillomavirus testing for underscreened populations: cost-effectiveness and affordability in three country settings.
    BMC Public Health. 2025;25:2570.
    PubMed    
    Abstract available

  30. DESTAW A, Getachew S, Getachew E, Shita A, et al
    Follow-up rescreening uptake and persistent positive rates among women after positive cervical cancer screening results in Ethiopia: a longitudinal cross-sectional study.
    BMJ Open. 2025;15:e099955.
    PubMed    
    Abstract available

  31. HITOVA-TOPKAROVA D, Payakova V, Yordanov A, Kostova-Lefterova D, et al
    Locally Advanced Cervical Cancer in a Patient with Epidermolysis Bullosa Treated with Concurrent Chemoradiotherapy and Electronic Brachytherapy.
    Reports (MDPI). 2025;8:12.
    PubMed    
    Abstract available

  32. SALIH SR, Abdulla KN, K Awn A, Yasin YS, et al
    Impact of Esomeprazole, Ciprofloxacin and Their Combination on Cervical Cancer Cell Line Proliferation: A Focus on Heat Shock Protein 70 Modulation.
    Asian Pac J Cancer Prev. 2025;26:2455-2466.
    PubMed    
    Abstract available

  33. IROWA O, Adeyeye OS, Ogwuche PE, Otache AE, et al
    Knowledge Attitude and Determinants of Cervical Cancer Screening Uptake Among Age-Eligible Women and Male Partners in Makurdi North-Central Nigeria.
    Asian Pac J Cancer Prev. 2025;26:2389-2396.
    PubMed    
    Abstract available

  34. DOGAN NU, Dogan S
    New Surgical Techniques for Early Stage Cervical Cancer Under 2 cm : Is There Enough Evidence?
    Asian Pac J Cancer Prev. 2025;26:2319-2325.
    PubMed    
    Abstract available

  35. LI Y, Wang H, Yang J, Wang H, et al
    Triage accuracy of a six-gene methylation detection for high-risk HPV-positive Chinese women.
    Afr J Reprod Health. 2025;29:137-147.
    PubMed    
    Abstract available

  36. NISHIO S
    Bintrafusp alfa and its unsuccessful development journey towards cervical cancer treatment.
    Expert Opin Biol Ther. 2025 Jul 30:1-3. doi: 10.1080/14712598.2025.2541795.
    PubMed    


  37. WANG Z, Chu R, Wu N, Yuan M, et al
    Development and validation of prognostic prediction models for early-stage cervical cancer patients based on pathological intermediate-risk factors.
    Ther Adv Med Oncol. 2025;17:17588359251359461.
    PubMed    
    Abstract available

  38. CHEN J, Yu H, Lin Y, Hu D, et al
    Real-world data of cadonilimab in recurrent or metastatic cervical cancer in China: a multicentric study.
    Front Immunol. 2025;16:1611696.
    PubMed    
    Abstract available

  39. PEREIRA SDG, Nobre L, Ribeiro M, Carvalho P, et al
    Targeting under-screened women in cervical cancer: combining self-sampling and human papillomavirus testing with a strategic reminder plan.
    Eur J Public Health. 2025 Jul 28:ckaf122. doi: 10.1093.
    PubMed    
    Abstract available

  40. MIZUTA Y, Yamanoi K, Miyamoto T, Mizuno R, et al
    Therapeutic impact of neoadjuvant chemotherapy on lymph node metastasis in locally advanced cervical cancer.
    J Obstet Gynaecol Res. 2025;51:e70022.
    PubMed    
    Abstract available

  41. HU S, Li Y, Hu M, Wang Z, et al
    Risk factors for hrHPV infection with cervical lesions patient in Anhui Province of China from 2021 to 2024: A retrospective study.
    Medicine (Baltimore). 2025;104:e43384.
    PubMed    
    Abstract available

  42. AGNANTI E, Tsakogiannis D, Papadopoulos T, Arvanitidis KI, et al
    Disruption Events in the HPV18 E1 and E2 Genes in Precancerous Cervical Lesions.
    Int J Mol Sci. 2025;26:6974.
    PubMed    
    Abstract available

  43. QUINTANA GR, Herrera N, Santibanez-Palma JF, Escudero-Pasten J, et al
    Psychometric Evidence of the Pap Smear Test and Cervical Cancer Beliefs Scale (CPC-28) in Aymara Women from Chile.
    Int J Environ Res Public Health. 2025;22:1025.
    PubMed    
    Abstract available

  44. MBONA SV, Ananth A, Chifurira R
    A Bayesian Logistic Regression Approach to Investigating the Determinants Associated with Never Having Been Screened for Cervical Cancer Amongst Child-Bearing-Age Women in Jordan.
    Int J Environ Res Public Health. 2025;22:1000.
    PubMed    
    Abstract available

  45. MERDZHANOVA-GARGOVA Y, Ivanova M, Mollova-Kysebekirova A, Mihaylova A, et al
    Advancements in Cervical Cancer Screening: Enhancing HPV Testing and Triage Strategies for Improved Risk Assessment.
    Biomedicines. 2025;13:1768.
    PubMed    
    Abstract available

  46. GIANSANTI D, Lastrucci A, Pirrera A, Villani S, et al
    AI in Cervical Cancer Cytology Diagnostics: A Narrative Review of Cutting-Edge Studies.
    Bioengineering (Basel). 2025;12:769.
    PubMed    
    Abstract available

  47. YESILFIDAN D, Ozkan M, Adana F
    Comparison of cervical Cancer-Related knowledge, attitudes, and behaviors among women in urban and rural regions.
    BMC Public Health. 2025;25:2561.
    PubMed    
    Abstract available

  48. WANG ZT, Dang CW, You RL, Li S, et al
    Age-period-cohort analysis of global, regional, and national cervical cancer prevalence trends in women of childbearing age (15-49 years), 1990-2021.
    BMC Womens Health. 2025;25:374.
    PubMed    
    Abstract available

  49. CHAPOLA JC, Chinula L, Dunda W, Bula A, et al
    Exploring perceived barriers and facilitators to using mobile phone technology for delivering HPV test results in malawi: a qualitative study with HPV-Screened women, healthcare providers, and health officials.
    BMC Public Health. 2025;25:2563.
    PubMed    
    Abstract available

  50. SUN Q, Yang Z, Li P, Wang X, et al
    Retraction Note to: A novel miRNA identified in GRSF1 complex drives the metastasis via the PIK3R3/AKT/NF-kappaB and TIMP3/MMP9 pathways in cervical cancer cells.
    Cell Death Dis. 2025;16:569.
    PubMed    


  51. BEGLARYAN H, Khattar J, Kassee C, Barrett K, et al
    Disability and receipt of the Papanicolaou test for cervical cancer screening: A systematic review and meta-analysis.
    Prev Med. 2025;199:108376.
    PubMed    
    Abstract available

  52. CAI Y, Jiang N, Wang Y, Ji M, et al
    Association and interaction network analysis of immune cell subgroups in cervical cancer microenvironment based on Mendelian randomization.
    Discov Oncol. 2025;16:1412.
    PubMed    
    Abstract available

  53. MOHAMMED GEBABA E, Aweke GT, Addissie A, Assefa M, et al
    Factors affecting cervical cancer knowledge among women in Addis Ababa, Ethiopia: A population-based study.
    PLOS Glob Public Health. 2025;5:e0004961.
    PubMed    
    Abstract available

  54. WANG S, Mao Z, Liu Y, Lan C, et al
    Apo10 and TKTL1 in blood macrophages as non-invasive biomarkers for early detection of cervical cancer.
    Cell Oncol (Dordr). 2025 Jul 28. doi: 10.1007/s13402-025-01092.
    PubMed    
    Abstract available

  55. STITES S, Kelly P, Glenn J, Smith S, et al
    Community-Engaged Research Informing Upstream Determinants of Cancer Prevention for People with Criminal Legal System Involvement.
    Prog Community Health Partnersh. 2025;19:227-235.
    PubMed    
    Abstract available

  56. HAMID MKI, Hasneen S, Lima AK, Shawon SR, et al
    Cervical cancer trends, HPV vaccine utilization, and screening in low- and lower-middle-income countries: an updated review.
    Ther Adv Vaccines Immunother. 2025;13:25151355251356646.
    PubMed    
    Abstract available

  57. SINGH S, Mehta N, Noh M, Bond K, et al
    Weight-Based Health Care Discrimination and Cervical Cancer Screening Among Black Sexual and Gender Minoritized Assigned Female at Birth Adults in the United States.
    Health Equity. 2025;9:22-30.
    PubMed    
    Abstract available

  58. SONG T, Chen X, Chen F, Wan Q, et al
    Unraveling the prognostic puzzle: in-depth exploration of lymph node metrics for surgically treated FIGO stage IB-IIA cervical cancer-focus on the number of positive lymph nodes and the lymph node ratio.
    Int J Surg. 2025 Jul 15. doi: 10.1097/JS9.0000000000003033.
    PubMed    
    Abstract available

  59. LOFLING LL, Stoer NC, Botteri E, Fortner RT, et al
    Statins and the risk of gynecological cancer: a Norwegian population-based cohort study.
    Int J Epidemiol. 2025;54:dyaf133.
    PubMed    
    Abstract available

  60. LI W, Wang M, Du P, Han A, et al
    CDDO-Me triggers ROS-dependent ferroptosis and apoptosis in cervical cancer via targeting PI3K/Nrf2 pathway.
    Food Chem Toxicol. 2025;204:115664.
    PubMed    
    Abstract available

  61. BAZMI H, Asghari AA, Jalali MB, Rezvan L, et al
    Upregulation of PCAT1, PCAT2, and PCAT3 LncRNAs in cervical cancer patients and their diagnostic value.
    BMC Res Notes. 2025;18:326.
    PubMed    
    Abstract available

  62. NIE F, Si H, Qin H, Wang Y, et al
    Cervical and vaginal metastases from ascending colon cancer: a case report and literature review.
    BMC Womens Health. 2025;25:369.
    PubMed    
    Abstract available

  63. MA Z, Liu M, Yuan Q, Tang Z, et al
    Differences in Cervical Cancer Stage at Diagnosis and Survival Outcomes Among Asian, Native Hawaiian, and Other Pacific Islander Patients and White Patients.
    Ann Epidemiol. 2025 Jul 23:S1047-2797(25)00209.
    PubMed    
    Abstract available

  64. CHEN B, Yao X, Zhang S, Hu X, et al
    Highly sensitive detection of cervical cancer biomarker miR-21 using surface-enhanced Raman scattering (SERS).
    Spectrochim Acta A Mol Biomol Spectrosc. 2025;344.
    PubMed    
    Abstract available

  65. ZHOU Q, Yu H, Dong A, Yi J, et al
    The TRIM22-CDT2 axis is the key mediator of the p53-Rb signals in growth control of HPV-positive cervical carcinoma cells.
    Neoplasia. 2025;67:101211.
    PubMed    
    Abstract available

  66. GUO X, Wang M, Yan S, Hu K, et al
    Clinicopathological characteristics and prognosis of cervical adenocarcinoma across diverse histological subtypes.
    Tumori. 2025;111:331-348.
    PubMed    
    Abstract available

  67. HUDDLESTON C, Mani C, Sah N, Courtney E, et al
    Evaluating Efficacy of Cervical HPV-HR DNA Testing as Alternative to PET/CT Imaging for Posttreatment Cancer Surveillance: Retrospective Proof-of-Concept Study.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1264-1268.
    PubMed    
    Abstract available

  68. LI Y, Qin C, Li KT, He Y, et al
    Feasibility and Acceptability of Pay-it-forward in Increasing Uptake of HPV Vaccination among 15- to 18-Year-Old Girls in China: Pilot RCT Results.
    Cancer Prev Res (Phila). 2025;18:485-492.
    PubMed    
    Abstract available

  69. AGBENYEGA T, Schuind AE, Adjei S, Antony K, et al
    Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial.
    Lancet Infect Dis. 2025;25:861-872.
    PubMed    
    Abstract available

  70. LEVIN G, Monk BJ, Pothuri B, Coleman R, et al
    Racial and ethnic enrollment disparities in clinical trials leading to FDA approvals for gynecologic malignancies.
    Am J Obstet Gynecol. 2025 Jan 23:S0002-9378(25)00048.
    PubMed    
    Abstract available

  71. LI D, Zhang W, Stinson J, Jibb L, et al
    Navigating HPV Vaccination: a Qualitative Study on Chinese Women's Decision-Making Experiences.
    J Cancer Educ. 2025;40:616-625.
    PubMed    
    Abstract available

  72. PAZZAGLIA E, Pasquini P, Jamaer E, Traen K, et al
    Pioneering telesurgery in gynecology: the first European case of total hysterectomy.
    J Robot Surg. 2025;19:460.
    PubMed    
    Abstract available

  73. SUN H, Wang H, Liu Y, Xu H, et al
    Comparison of the SureX((R)) HPV genotyping test with the Digene Hybrid Capture((R)) 2 test in cervical cancer screening.
    Front Oncol. 2025;15:1627935.
    PubMed    
    Abstract available

  74. CHEN MM, Zhang BQ, Luan YS, Sun GL, et al
    The diagnostic of PAX1 gene methylation in cervical lesions and its role in the triage of non-16/18 HR-HPV positive.
    Front Immunol. 2025;16:1634297.
    PubMed    
    Abstract available

  75. LI Y, Lin Z, Lin G, Zhao Z, et al
    Revolutionizing cervical cancer treatment: single-cell sequencing of TSPAN1+ tumor EPCs and immune checkpoints to assess drug sensitivity and optimize therapy.
    Front Immunol. 2025;16:1574174.
    PubMed    
    Abstract available

  76. CHUKWUEMEKA I, Sudeshna D, Yuting G, Swati R, et al
    Bridging AI, NLP, and Digital Health: A Bi-Directional Learning Experience at Emory University.
    Stud Health Technol Inform. 2025;329:1822-1823.
    PubMed    
    Abstract available

  77. TAJIRIAN T, Adams N, Nicolle J, DeLasa C, et al
    Digitally Empowered: Boosting Cervical and Breast Cancer Screening for Patients with Severe Mental Illness Through Smart EHR Solutions.
    Stud Health Technol Inform. 2025;329:367-370.
    PubMed    
    Abstract available

  78. XIAO WQ, Lee DH, Kim H, Zhang HN, et al
    Ethyl beta-carboline-3-carboxylate targets PRDX5/c-Jun axis for novel therapeutic strategy against cervical cancer.
    Discov Oncol. 2025;16:1498.
    PubMed    
    Abstract available

  79. BARRA MJ, Wilkinson AF, Ma AE, Goli K, et al
    One-hour extraction-free loop-mediated isothermal amplification HPV DNA assay for point-of-care testing in Maputo, Mozambique.
    Nat Commun. 2025;16:7295.
    PubMed    
    Abstract available

  80. WYER A, Louis M, Okunlola OI, Richardson R, et al
    Enterocutaneous Fistula: A Challenging Complication in Cervical Cancer Management.
    Cureus. 2025;17:e87475.
    PubMed    
    Abstract available

  81. CHADHA L, Sharma P, Bhide N, Arya I, et al
    Empowering perimenopausal women: A critical examination of opportunistic teaching on cervical cancer awareness.
    J Educ Health Promot. 2025;14:268.
    PubMed    
    Abstract available

  82. ZHONG L, Li J, Zhong J, Zhang Y, et al
    IFI16 Induced by p53 Activates the NF-kappaB Pathway to Counteract Cisplatin-Induced Apoptosis in Cervical Cancer Cells.
    J Cell Mol Med. 2025;29:e70728.
    PubMed    
    Abstract available

  83. OKUMA K, Murakami N, Inaba K, Kashihara T, et al
    Gel spacer-assisted salvage brachytherapy for pelvic recurrence after definitive chemoradiotherapy in cervical cancer: A single-institution retrospective study.
    Brachytherapy. 2025 Aug 5:S1538-4721(25)00246.
    PubMed    
    Abstract available

  84. DE LA PENA R, Peterson E
    Common Cancers in the Pregnant Patient.
    Obstet Gynecol Clin North Am. 2025;52:507-517.
    PubMed    
    Abstract available

  85. WANG H, Shang K, Tang K, Duan Z, et al
    Development of palmatine chloride-loaded chitosan nanoparticles for enhanced and safe cervical cancer therapy.
    Int J Biol Macromol. 2025 Aug 4:146579. doi: 10.1016/j.ijbiomac.2025.146579.
    PubMed    
    Abstract available

  86. YANG M, Lu Y, Han L, He Z, et al
    A Novel Endophytic Fungus, Alternaria semiverrucosa, and Its Ethyl Acetate Extract Inhibit the Proliferation, Migration, and Invasion of Cervical Cancer Cells.
    Chem Biodivers. 2025 Aug 6:e00945. doi: 10.1002/cbdv.202500945.
    PubMed    
    Abstract available

  87. POCOBELLI G, Lykken J, Haas JS, Tiro J, et al
    Positive predictive value of cervical cancer screening results recommended for colposcopy by human papillomavirus vaccination status at 3 U.S. healthcare systems.
    Cancer Causes Control. 2025 Aug 6. doi: 10.1007/s10552-025-02039.
    PubMed    
    Abstract available

  88. AL-BITAR A, Kouli A, Janoud O, Harb A, et al
    Breast and Cervical Cancer Gaps in Displaced Lebanese Women in Syria.
    JAMA Netw Open. 2025;8:e2525652.
    PubMed    
    Abstract available

  89. SILVA GO, Braga YS, Reis IF, Alessio Junior LE, et al
    Cervical cancer mortality: descriptive study and time series analysis, Mato Grosso, 2013-2022.
    Epidemiol Serv Saude. 2025;34:e20240503.
    PubMed    
    Abstract available

  90. LIMA BG, Barros MBA
    Prevalence and social inequalities in the use of cancer screening tests in Campinas, Brazil (ISACamp 2014/15).
    Rev Bras Epidemiol. 2025;28:e250043.
    PubMed    
    Abstract available

  91. HUANG S, Gentil LG, Schmidt C, Cullum R, et al
    Comparative clinical performance of Alinity m HR HPV, cobas 4800 HPV, and cobas 6800 HPV for cervical cancer screening.
    Microbiol Spectr. 2025 Aug 6:e0058925. doi: 10.1128/spectrum.00589.
    PubMed    
    Abstract available

  92. MANGA S, Yuanfan Y, Scarinci I, Nulah K, et al
    Comparing a "See-and-Treat" HPV-Based to VIA-Based Cervical Cancer Prevention Strategies Among Women Living with HIV in Cameroon: A Pilot Study.
    Res Sq [Preprint]. 2025 Jul 28:rs.3.rs-7097928. doi: 10.21203/rs.3.rs-7097928.
    PubMed    
    Abstract available

  93. SULEJMANI H, Vasilevski F, Krsteska B, Tanevska Zrmanovska A, et al
    Radiation-induced rectal leiomyosarcoma in a cervical cancer survivor: a case report.
    J Surg Case Rep. 2025;2025:rjaf609.
    PubMed    
    Abstract available

  94. LIANG X, Zeng XT, Hong ZL, Lin XY, et al
    Perfluorobutane CEUS for early-stage cervical lymphoma: diagnostic value of the postvascular phase starfield sign.
    Sci Rep. 2025;15:28486.
    PubMed    
    Abstract available

  95. YANG Y, Guo Z
    Prognostic value of Linc00662/miR-16-5p/FASN in cervical cancer and regulation of tumor progression.
    Hereditas. 2025;162:151.
    PubMed    
    Abstract available

  96. JING Y, Chen J, Lin F, Huang X, et al
    Multiple high-risk human papillomavirus infections exacerbate cervical lesion risk: epidemiological evidence from suining, Sichuan.
    Virol J. 2025;22:268.
    PubMed    
    Abstract available

  97. CHAND T, Vaishanavaa P, Dubey AK, Misra G, et al
    Identification of hub genes as potential diagnostic biomarkers for cervical cancer: A bioinformatic approach.
    Comput Biol Chem. 2025;119:108605.
    PubMed    
    Abstract available

  98. NGUYEN AM, Waldron-Corredor A, Liu FY, Yun X, et al
    Breast, Cervical, and Colorectal Cancer Screening Among New Jersey Medicaid Enrollees: 2017-2022.
    JCO Clin Cancer Inform. 2025;9:e2500055.
    PubMed    
    Abstract available

  99. SUSETIATI DA, Pudjiati SR, Wirohadidjojo YW, Chandra LA, et al
    Effectiveness of Lactobacillus therapy in women with cervical human papillomavirus infection: A systematic review and meta-analysis.
    J Int Med Res. 2025;53:3000605251363006.
    PubMed    
    Abstract available

  100. SOROKIN P, Kulikova S, Stepanyan A, Davtyan H, et al
    Total mesometrial resection for the treatment of cervical cancer - an exploratory study of feasibility, safety and oncological outcomes in developing countries.
    Klin Onkol. 2025;38:201-208.
    PubMed    
    Abstract available

  101. SOUMAROVA R, Havlik J
    Current complex treatment for cervical cancer.
    Klin Onkol. 2025;38:185-191.
    PubMed    
    Abstract available

  102. TAN X, Yang J, Li Y, Wan K, et al
    Development of Z(HPV16E7)- granzyme B immunoaffitoxin: dual mechanisms targeting hpv16-positive cervical cancer through epithelial-mesenchymal transition inhibition and cell death.
    Front Immunol. 2025;16:1616715.
    PubMed    
    Abstract available

  103. YIN B, Chen C, Huang B, Ding J, et al
    Oncogenic CMTM6 drives M2a macrophages formation and fuels cervical cancer progression.
    Front Immunol. 2025;16:1621816.
    PubMed    
    Abstract available

  104. TEIXEIRA AL, Dias F, Gil da Costa RM
    Editorial: Exploring HPV's role in genitourinary cancers beyond cervical cancer.
    Front Oncol. 2025;15:1658619.
    PubMed    


  105. ZHANG X, Xu J
    Alveolar rhabdomyosarcoma of cervix: A case report.
    Medicine (Baltimore). 2025;104:e43675.
    PubMed    
    Abstract available

  106. LI L, Yao M, Li L, Shi S, et al
    Synchronous endometrial/cervical and ovarian/fallopian tube carcinoma: a genome-wide mutation analysis.
    J Pathol Clin Res. 2025;11:e70040.
    PubMed    
    Abstract available

  107. WANG W, Yang G, Liu Y, Wei L, et al
    Multimodal deep learning model for prognostic prediction in cervical cancer receiving definitive radiotherapy: a multi-center study.
    NPJ Digit Med. 2025;8:503.
    PubMed    
    Abstract available

  108. LI M, Wu X, Liu X, Wen M, et al
    Effects of intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) on survival benefits and poor prognostic factors in patients with cervical cancer.
    Biomed Eng Online. 2025;24:96.
    PubMed    
    Abstract available

  109. LOPEZ-UBEDA P, Martin-Noguerol T, Luna A
    Natural language processing evaluation of trends in cervical cancer incidence in radiology reports: A ten-year survey.
    Radiography (Lond). 2025 Aug 4:103117. doi: 10.1016/j.radi.2025.103117.
    PubMed    
    Abstract available

  110. XU L, Ma C, Cuschieri K, Bonde J, et al
    Clinical Validation of the Venus HPV Full-Genotyping Assay for Cervical Cancer Screening in the VALGENT-4 Framework.
    J Med Virol. 2025;97:e70527.
    PubMed    
    Abstract available

  111. SAVELIEV GM, Varlas VN, Piron-Dumitrascu M, Suciu N, et al
    Prioritizing the risk of cervical cancer: findings from the SCCUT Multicentre Initiative.
    J Med Life. 2025;18:590-593.
    PubMed    
    Abstract available

  112. WANG J, Chen Z, Guan M, Ma Z, et al
    The Persistent Threat of Chronic Inflammation on the Mortality Among Cervical Cancer Survivors: A Mendelian Randomization and Machine Learning Analysis Using UK Biobank and Chinese Cohort Data.
    J Inflamm Res. 2025;18:10267-10282.
    PubMed    
    Abstract available

  113. FOLINO G, Zent I, Eason L, Murugan V, et al
    Temporal trends of cervical cancer demographics: a CDC WONDER database study.
    Front Oncol. 2025;15:1567305.
    PubMed    
    Abstract available

  114. CHARTIAN MS, Chellani G, Singh M, Dhankar N, et al
    Interobserver Variability and Comparison of Liquid-Based Cytology Versus Conventional Pap Smear for Cervical Cancer Screening in a High-Risk Population.
    Cureus. 2025;17:e87210.
    PubMed    
    Abstract available

  115. DE SOUZA ATB, de Sousa Santos DL, Medeiros FS, de Carvalho KTC, et al
    Comparison of IL-10 gene promoter polymorphisms and haplotypes between high-grade squamous intraepithelial lesions or cervical cancer and negative cervical cytology.
    Sci Rep. 2025;15:28330.
    PubMed    
    Abstract available

  116. ALVAREZ-QUEZADA OA, Espino-Nunez YE, Valencia-Gomez LE, Martel-Estrada SA, et al
    Controlled release of curcumin and gemcitabine from mucoadhesive chitosan-gelatin polymeric ovules: Cytotoxic effects on cervical cancer cells.
    Eur J Pharm Biopharm. 2025 Aug 1:114834. doi: 10.1016/j.ejpb.2025.114834.
    PubMed    
    Abstract available

  117. SHI R, Qi W, Wang Z, Cai J, et al
    High-risk human papillomavirus genotype distribution and attribution to cervical lesions in a Shanxi Province screening population.
    Sci Rep. 2025;15:28217.
    PubMed    
    Abstract available

  118. GULLE BT, Tozduman B, Oren Celik MM
    Determinants of cancer screening participation in Turkiye: a nationwide study of demographic, socioeconomic, and lifestyle factors.
    BMC Public Health. 2025;25:2637.
    PubMed    
    Abstract available

  119. YANG WJ, Lee SH, Kim YJ, Kim KG, et al
    Comparison of performance of cervical cancer grading based on acetowhite areas.
    Sci Rep. 2025;15:28258.
    PubMed    
    Abstract available

  120. LIU T, Lu D, Wu X
    Cadonilimab in advanced cervical cancer: the COMPASSION-16 trial - Authors' reply.
    Lancet. 2025;406:446.
    PubMed    


  121. CHENG C
    Cadonilimab in advanced cervical cancer: the COMPASSION-16 trial.
    Lancet. 2025;406:445.
    PubMed    


  122. HUANG L, We Y, Chen F
    Cadonilimab in advanced cervical cancer: the COMPASSION-16 trial.
    Lancet. 2025;406:445-446.
    PubMed    


  123. WANG J, Zhang J, Wang T, Rong C, et al
    Notch signaling pathway in cervical cancer: From molecular mechanism to therapeutic potential.
    Cell Signal. 2025;135:112042.
    PubMed    
    Abstract available

  124. CHEN S, Dai H, Hu S, Gao T, et al
    Novel triple-target panels utilizing methylation-sensitive restriction enzyme-based quantitative PCR for detecting advanced cervical precancers and cancers among high-risk HPV-positive women.
    J Transl Med. 2025;23:857.
    PubMed    
    Abstract available

  125. TSEMENTZI D, Meador R, Eng T, Shelton J, et al
    Associations among HPV persistence, the vaginal microbiome, and cervical cancer recurrence.
    J Transl Med. 2025;23:858.
    PubMed    
    Abstract available

  126. MHANGO P, Kumitawa A, Malata MP, Tang JH, et al
    Acceptability, feasibility and appropriateness of integrating HPV self-sampling for cervical cancer screening into voluntary family planning services in Malawi.
    BMC Public Health. 2025;25:2615.
    PubMed    
    Abstract available

  127. CHAN K, Ballantyne H, Liu ZA, Milosevic M, et al
    Intra-operative process efficiency for in-room MRI-guided combined intracavitary/interstitial brachytherapy for cervical cancer.
    Brachytherapy. 2025 Jul 31:S1538-4721(25)00124.
    PubMed    
    Abstract available

  128. KRZESAJ PK, Seydafkan S, Miller AI, Chen HT, et al
    HDM-2-Targeting Peptide PNC-27 Kills Cervical Cancer Cells but not Normal Cervical Cells.
    Ann Clin Lab Sci. 2025;55:347-353.
    PubMed    
    Abstract available

  129. SELLAMI I, Sais E, Souare F, Becquart C, et al
    Fertility Preservation in Women with Cervical Cancer.
    Semin Reprod Med. 2025 Aug 1. doi: 10.1055/s-0045-1810055.
    PubMed    
    Abstract available

  130. LI J, Huang Y, Tao J, Yang H, et al
    Evaluation of topical photodynamic therapy (PDT) with 5-aminolevulinic acid (5-ALA) for cervical intraepithelial neoplasia with human papillomavirus (HPV) infection: a retrospective comparative study versus loop electrosurgical excision procedure (LEE
    Photodiagnosis Photodyn Ther. 2025;54:104697.
    PubMed    
    Abstract available

  131. CHEN R, Xu J, Ye C, Lu L, et al
    Efficacy of 5-aminolevulinic acid photodynamic therapy versus observation for cervical low-grade squamous intraepithelial lesion with type 3 transformation zone.
    Photodiagnosis Photodyn Ther. 2025;54:104679.
    PubMed    
    Abstract available

  132. STEPHENSON AL, Sharpe I, Sykes J, Ma X, et al
    Primary care physician involvement increases likelihood of cancer screening in people with cystic fibrosis: A population-based study from Ontario, Canada.
    J Cyst Fibros. 2025;24:698-703.
    PubMed    
    Abstract available

  133. MATEEN AZHAR M, Maqbool T, Ali F, Altaf A, et al
    Adefovir anticancer potential: Network pharmacology, anti-proliferative and apoptotic effects in HeLa cells.
    Biomol Biomed. 2025;25:1751-1764.
    PubMed    
    Abstract available

  134. AL HINAI F, Al Shamsi R, Al Husaini S, Al Rashdi A, et al
    The Role of Cytokeratin 7 and Cytokeratin 19 Immunohistochemistry in the Evaluation of Human Papillomavirus-Induced Cervical Squamous Precursor Epithelial Lesions.
    Pathobiology. 2025;92:216-223.
    PubMed    
    Abstract available

  135. CHAN DNS, Choi KC, Lee PPK, So WKW, et al
    The Effects of Motivational Interviewing on Promoting Human Papillomavirus Vaccination Initiation and Completion Among South Asian Mother/Daughter Dyads: A Pilot Randomised Controlled Trial.
    Int J Behav Med. 2025;32:574-585.
    PubMed    
    Abstract available

  136. VALLEY TM, White E, Foreman A, Chavez A, et al
    Development of a Cervical Cancer Screening Program in Rural Guatemala.
    Glob Health Sci Pract. 2025;13:e2400282.
    PubMed    
    Abstract available

  137. MA YM, Xia WL, Wang DB, Wu H, et al
    [Application of CT guided percutaneous interstitial brachytherapy in the treatment of recurrent cervical cancer with isolated lesions in the radiated field].
    Zhonghua Zhong Liu Za Zhi. 2025;47:745-749.
    PubMed    
    Abstract available

  138. ZHAO C, Wang T, Lu Y, Zhou Y, et al
    Copper-overload promotes ferroptosis in cervical cancer cells by upregulating HMOX1 expression.
    Discov Oncol. 2025;16:1549.
    PubMed    
    Abstract available

  139. XU L, Li Y, Lu J
    Comparison of outcomes between laparoscopic and open radical hysterectomy for early-stage cervical cancer in women with body mass index greater than 24.
    J Obstet Gynaecol Res. 2025;51:e70041.
    PubMed    
    Abstract available

  140. VAN DER HOEVEN NMA, van den Brule AJC, van Beekhuizen HJ, de Kok IMCM, et al
    Perspective of pregnant women on feasibility of integrating cervical cancer screening into antenatal care in the Netherlands: a questionnaire study.
    Eur J Public Health. 2025 Aug 14:ckaf121. doi: 10.1093.
    PubMed    
    Abstract available

  141. JIN G, Fan X, Liang X, Dai H, et al
    Identification and validation of ubiquitination-related genes for predicting cervical cancer outcome.
    Front Genet. 2025;16:1578075.
    PubMed    
    Abstract available

  142. ABEBE LG, Wondimagegnehu A, Labban LA, Teka B, et al
    Informed consent in cervical cancer screening research in Butajira district, Ethiopia.
    Glob Bioeth. 2025;36:2542593.
    PubMed    
    Abstract available

  143. LIU X, Zhao Y, Meng X, Gao Z, et al
    Vaginal bacteria and cervical cancer: a bibliometric analysis of trends and themes.
    Front Microbiol. 2025;16:1615944.
    PubMed    
    Abstract available

  144. LI Y, Deng J, Liu Y, Yu S, et al
    HPV infection and the immune microenvironment in cervical cancer.
    Front Immunol. 2025;16:1645019.
    PubMed    
    Abstract available

  145. BOONKATE S, Karnchanabanyong W, Ruengkhachorn I, Kuljarusnont S, et al
    Significance of Genotype-Specific High-Risk Human Papillomavirus Testing in Cervical Cancer Screening: A Hospital-Based Study.
    J Med Virol. 2025;97:e70561.
    PubMed    
    Abstract available

  146. PLOTTI F, Ficarola F, Fais G, De Cicco Nardone C, et al
    The Use of Self-Sampling Devices via a Smartphone Application to Encourage Participation in Cervical Cancer Screening: A Pilot Study.
    J Clin Med. 2025;14:5569.
    PubMed    
    Abstract available

  147. BARTUSIK-AEBISHER D, Saad MA, Przygorzewska A, Aebisher D, et al
    Recent Advances in Nanoparticle and Nanocomposite-Based Photodynamic Therapy for Cervical Cancer: A Review.
    Cancers (Basel). 2025;17:2572.
    PubMed    
    Abstract available

  148. LI Q, Zhou Z, Li X, Lan Q, et al
    DGKbeta accelerates the progression of cervical cancer through ANGPT4-mediated tumor angiogenesis.
    Mutat Res. 2025;831:111913.
    PubMed    
    Abstract available

  149. LEE J, Ismail-Pratt I, Machalek DA, Kumarasamy S, et al
    Correction: From barriers to opportunities from COVID-19 pandemic: Stakeholder perspectives on cervical cancer screening programs in LMICs of the Asia-Pacific region.
    PLOS Glob Public Health. 2025;5:e0005067.
    PubMed    
    Abstract available

  150. AMBOREE TL, Montealegre JR, Damgacioglu H, Orr B, et al
    County-Level Cervical Cancer Screening Coverage and Differences in Incidence and Mortality.
    JAMA Netw Open. 2025;8:e2526709.
    PubMed    


  151. ADEKUNLE T, Adekunle T, Afolabi E
    Beyond Knowledge: Trust and the Engagement of Newly Arrived Refugee Women in Cervical Cancer Prevention.
    J Immigr Minor Health. 2025 Aug 13. doi: 10.1007/s10903-025-01756.
    PubMed    
    Abstract available


  152. Retraction: Inhibition of Mircorna-766-5p Attenuates the Development of Cervical Cancer Through Regulating SCAI.
    Technol Cancer Res Treat. 2025;24:15330338251363342.
    PubMed    



  153. Retraction: MicroRNA-96-5p Facilitates the Viability, Migration, and Invasion and Suppresses the Apoptosis of Cervical Cancer Cells by Negatively Modulating SFRP4.
    Technol Cancer Res Treat. 2025;24:15330338251363351.
    PubMed    


  154. RAMATHUBA DU, Ngambi D
    Assessing the Quality of the Endocervical Component: Pitfalls to Cervical Cancer Screening in Limpopo Province, South Africa.
    Cancer Control. 2025;32:10732748251363746.
    PubMed    
    Abstract available

  155. LIU S, Jiang Z, He J, Niu X, et al
    An Advanced Network Pharmacology Study Reveals the Multi-Pathway and Multi-Gene Regulatory Mechanism of Jinbai Heat-clearing Prescription in HPV-induced Cervical Cancer via Molecular Docking and Microarray Data Analysis.
    Curr Med Chem. 2025 Aug 8. doi: 10.2174/0109298673377164250710100915.
    PubMed    
    Abstract available

  156. RASHWAN HH, Ali MH, Mostafa MM, Ramadan R, et al
    Insights into the tripartite relationship between cervical cancer, human papillomavirus, and the vaginal microbiome: a mega-analysis.
    Hum Genomics. 2025;19:89.
    PubMed    
    Abstract available

  157. DEMILEW YM, Wassie GT, Guadie HA, Asemahagn MA, et al
    The effect of health education on hypertension, diabetes mellitus, and cervical cancer screening service utilization among eligible adults in a district around Bahir Dar city, Ethiopia: a cluster randomized controlled community trial.
    BMC Public Health. 2025;25:2736.
    PubMed    
    Abstract available

  158. YANG S, Zeng J, Wang Y, Tan Y, et al
    Single-cell and bulk transcriptome profiling reveals RNA-binding protein regulatory programs in cervical cancer.
    Sci Rep. 2025;15:29538.
    PubMed    
    Abstract available

  159. OSAKI N, Soyano T, Sutani S, Matsumoto H, et al
    Comparison of rectal and bladder dose between retractor insertion and gauze packing in intracavitary brachytherapy for cervical cancer.
    J Radiat Res. 2025 Aug 6:rraf042. doi: 10.1093.
    PubMed    
    Abstract available

  160. HOSSAIN MA, Khanam SJ, Khan MN, Oldroyd J, et al
    Correction: Barriers to cervical cancer screening among refugee women: A systematic review.
    PLOS Glob Public Health. 2025;5:e0005060.
    PubMed    
    Abstract available

  161. LUU XQ, Jun JK, Suh M, Oh JK, et al
    Cervical Cancer Screening, HPV Vaccination, and Cervical Cancer Elimination.
    JAMA Netw Open. 2025;8:e2526683.
    PubMed    
    Abstract available

  162. JI F, Xu L, Li J
    Sacral Neuromodulation for Post-Hysterectomy Hydroureteronephrosis in a Patient with Cervical Cancer: A Case Report.
    Am J Case Rep. 2025;26:e948967.
    PubMed    
    Abstract available

  163. DUAN Y, Chen A
    Letter to the editor: Surgical approach, preoperative LEEP/conization and patterns of recurrence and death in low-risk cervical cancer - exploratory analysis from the CCTG CX.5/SHAPE trial.
    Int J Surg. 2025 Aug 11. doi: 10.1097/JS9.0000000000003205.
    PubMed    


  164. INAMI K
    Cost-effectiveness of chemotherapy for advanced and recurrent cervical cancer: a systematic review.
    Front Health Serv. 2025;5:1616223.
    PubMed    
    Abstract available

  165. MURUGESAN B, Somasundram B, Samykannu G, Karuppiah P, et al
    Exploring lichen-derived compounds as potential anti-cervical cancer agents: an DFT and MD simulation analysis.
    In Silico Pharmacol. 2025;13:114.
    PubMed    
    Abstract available

  166. LU P, Qian W, Chen Q
    Intratumoral and peritumoral radiomics based on super-resolution T2-weighted imaging for prediction of normal-sized lymph node metastasis in cervical cancer.
    Acta Radiol. 2025 Aug 12:2841851251365509. doi: 10.1177/02841851251365509.
    PubMed    
    Abstract available

  167. DICKHOFF LRM, Kerkhof EM, Deuzeman HH, Barten DLJ, et al
    The versatility of evolutionary intelligent tri-objective treatment planning for cervical cancer brachytherapy.
    Med Phys. 2025;52:e18022.
    PubMed    
    Abstract available

  168. HUANG X, Li X, Li S, Wu J, et al
    Vaginal metabolic profiling reveals biomarkers characteristics of high-risk HPV infection and cervical lesions.
    J Obstet Gynaecol Res. 2025;51:e70035.
    PubMed    
    Abstract available

  169. BAI J, Li N, Ye H, Li X, et al
    AI-assisted cervical cytology precancerous screening for high-risk population in resource-limited regions using a compact microscope.
    Nat Commun. 2025;16:7429.
    PubMed    
    Abstract available

  170. SANTOS C, Roye J, Tucker J, Guevara C, et al
    Enhancing equity and efficiency in cervical screening uptake: a multidisciplinary quality improvement initiative.
    BMJ Open Qual. 2025;14:e003111.
    PubMed    
    Abstract available

  171. MULATI S, Shen F, Talihati Z, Zhang Y, et al
    Targeting RPS16 with cinnamaldehyde to suppress cervical cancer: inhibition of the PI3K/AKT pathway and degradation of HPV E6 and E7 proteins.
    Biochem Pharmacol. 2025;242.
    PubMed    
    Abstract available

  172. TAGUE C, Yokolo H, Makeda D, Ekouo J, et al
    Papillomavirus vaccine: a revolution in the fight against cervical cancer in the Democratic Republic of Congo.
    Ann Med Surg (Lond). 2025;87:4701-4703.
    PubMed    


  173. TOGAMI S, Furuzono N, Fukuda M, Kobayashi H, et al
    Comparative Long-term Outcomes of Laparoscopic Radical Hysterectomy with Sentinel Node Navigation and Open Surgery for Cervical Cancer.
    Gynecol Minim Invasive Ther. 2025;14:234-240.
    PubMed    
    Abstract available

  174. HUANG IC, Li PC, Ding DC
    Comparison of Prognosis between Abdominal and Laparoscopic Radical Hysterectomies in Early-stage Cervical Cancer: A Retrospective Cohort Study.
    Gynecol Minim Invasive Ther. 2025;14:246-253.
    PubMed    
    Abstract available

  175. ELSAID NMA, Ismail HAH, Salim AA, Kamal D, et al
    The effect of educational intervention program on knowledge and willingness of medical students to take cervical cancer screening and human papillomavirus vaccine: A quasi-experimental study.
    J Family Community Med. 2025;32:207-216.
    PubMed    
    Abstract available

  176. CHEE CSM, Tan SSN, Voon PJ, Augustin Y, et al
    Human papillomavirus (HPV) genotype distribution in Malaysia: A systematic review.
    BMC Infect Dis. 2025;25:1010.
    PubMed    
    Abstract available

  177. LUO S, Guo Y, Ye Y, Mu Q, et al
    Prediction of cervical cancer lymph node metastasis based on multisequence magnetic resonance imaging radiomics and deep learning features: a dual-center study.
    Sci Rep. 2025;15:29259.
    PubMed    
    Abstract available


  178. [Expert consensus on the early prevention of human papillomavirus related non-cervical diseases (2025 edition)].
    Zhonghua Yi Xue Za Zhi. 2025;105:2536-2550.
    PubMed    
    Abstract available

  179. LUO Y, Tang L, Zeng Z, Trang D, et al
    Ferroptosis and cellular senescence -Related Genes in Cervical Cancer: Mechanistic Insights from Multi-Omics and Clinical Sample Analysis.
    Transl Oncol. 2025;60:102487.
    PubMed    
    Abstract available

  180. BAO S, Wang Y, Hu Y, Lin S, et al
    Research trends in cervical cancer brachytherapy: a bibliometric analysis.
    Discov Oncol. 2025;16:1512.
    PubMed    
    Abstract available

  181. ZHANG Z, Liu M, An Y, Gao C, et al
    Targeting immune microenvironment in cervical cancer: current research and advances.
    J Transl Med. 2025;23:888.
    PubMed    
    Abstract available

  182. WANG C, Wang Y, Bian L, Wu F, et al
    Exploring dyadic coping, self-efficacy, and quality of life in patients with cervical cancer and their spousal caregivers: an actor-partner interdependence mediated model analysis.
    BMC Nurs. 2025;24:1042.
    PubMed    
    Abstract available

  183. ADAMS RA, Kelly H, Van der Merwe FH, Butt JL, et al
    Cervical precancer thermal ablation versus LLETZ excision comparative efficacy study in WLWH (TALL Study): protocol for a randomised clinical trial in South Africa.
    BMJ Open. 2025;15:e103282.
    PubMed    
    Abstract available

  184. BINDER U, Wenzl A, Lafleur J, Tempfer C, et al
    Loop electrosurgical excision procedure (LEEP) under local anesthesia: a retrospective analysis of 435 subsequent cases under a quality assurance program.
    Arch Gynecol Obstet. 2025;312:621-625.
    PubMed    
    Abstract available

  185. JANG J, Sun KH, Mann K, Barrett E, et al
    Patient Navigation Increases Breast, Cervical, and Colorectal Cancer Screening Among Immigrants in the U.S.: A Systematic Review.
    J Gen Intern Med. 2025;40:2358-2368.
    PubMed    
    Abstract available

  186. ELZEIN IM, Chamseddine A, Eltanboly A, Elzein A, et al
    Cervical cancer perceived risk factors behavior using logistic regression technique.
    J Biomed Res. 2025 Aug 25:1-12. doi: 10.7555/JBR.39.20250047.
    PubMed    
    Abstract available

  187. HAN HR, Lee YJ, Min D, Chepkorir J, et al
    Web-Based Delivery of an Effective Church-Based Intervention Program to Promote Cancer Screening (Community-based Health litEracy-focused intervention for breast and cervical Cancer Control) Among Korean Immigrant Women in the United States: Randomize
    JMIR Hum Factors. 2025;12:e66092.
    PubMed    
    Abstract available

  188. WANG H, Zhang Y, Li X, Hou Y, et al
    Understanding experiences and improvement needs of Chinese cervical cancer patients with external beam radiotherapy and 3D brachytherapy: A qualitative study using persona-driven journey maps.
    Eur J Oncol Nurs. 2025;78:102943.
    PubMed    
    Abstract available

  189. GYAN KG, Dunnack Yackel H, Effiong D, Escobar Jones C, et al
    Cervical Cancer Screening Beliefs and Practices Among Black Immigrant Women From Africa and the Caribbean Living in Massachusetts.
    Oncol Nurs Forum. 2025;52:371-381.
    PubMed    
    Abstract available

  190. SOETOMO CT, Gunawan MFB, De Liyis BG, Dewi PE, et al
    Unveiling The Impact of Prophylactic Para-Aortic Lymph Nodes Irradiation in Cervical Cancer: Meta-Analysis of Randomized Controlled Trials.
    Asian Pac J Cancer Prev. 2025;26:3075-3084.
    PubMed    
    Abstract available

  191. YOUSIF BJ, Abd Alwahab DH, Mohammed HA, Yasin YS, et al
    Antiproliferative Potential of Linagliptin-Rivaroxaban Mixture in Cervical Cancer: Mechanistic Insights into Targeting Mutant MAPK, RAS kinase Signal Protein.
    Asian Pac J Cancer Prev. 2025;26:3053-3064.
    PubMed    
    Abstract available

  192. KLANGPRAPAN N, Rodpenpear N
    The Performance of Modified Swede Colposcopic Index to Predict High Grade Cervical Intraepithelial Neoplasia and Cervical Cancer in the Real Clinical Practice, an External Validation Study.
    Asian Pac J Cancer Prev. 2025;26:2947-2952.
    PubMed    
    Abstract available

  193. SIREGAR TP, Wanandi SI, Darmiati S, Kusuma F, et al
    Development of a Predictive Model for Therapy Response in Advanced-Stage Cervical Cancer Using Apparent Diffusion Coefficient (ADC) Value and Quantitative T2 Tumor on MRI: Correlation with Survivin Expression.
    Asian Pac J Cancer Prev. 2025;26:2889-2897.
    PubMed    
    Abstract available

  194. M ZT, Pantagada N, Konuku K, Ad NK, et al
    In Vitro Anticancer Activities of Senna singueana Leaf Extracts against HeLa Cell Lines.
    Asian Pac J Cancer Prev. 2025;26:2869-2877.
    PubMed    
    Abstract available

  195. KHAN FZA, Mazhar SB, Itua I
    Knowledge, Attitudes and Practices of Cervical Cancer Screening among Women Attending Gynecology Clinics at Tertiary Care Hospitals in the Capital City of Pakistan: A Cross-Sectional Survey.
    Asian Pac J Cancer Prev. 2025;26:2819-2825.
    PubMed    
    Abstract available

  196. SIBARANI CNR, Salima S, Suardi D, Adrianto N, et al
    Efficacy and Safety of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiotherapy Compared to Concurrent Chemoradiotherapy Alone in Locally Advanced Cervical Cancer: A Systematic Review and Meta-Analysis.
    Asian Pac J Cancer Prev. 2025;26:2793-2802.
    PubMed    
    Abstract available

  197. YANUARINI TA, Mulyani S, Widyaningsih V
    Interventions to Improve the Uptake of Cervical Cancer Screening with Visual Inspection with Acetic Acid: A Scoping Review.
    Asian Pac J Cancer Prev. 2025;26:2755-2762.
    PubMed    
    Abstract available

  198. MCCORMACK M, Eminowicz G, Vaja S, Hackshaw A, et al
    INTERLACE: not a new standard for cervical cancer chemoradiation - Authors' reply.
    Lancet. 2025;406:807.
    PubMed    


  199. PETRIC P, Lindegaard JC, Schmid MP, Jurgenliemk-Schulz I, et al
    INTERLACE: not a new standard for cervical cancer chemoradiation.
    Lancet. 2025;406:806-807.
    PubMed    


  200. ZHOU M, Gao Y, Zhang Y, He L, et al
    CircZFR/YTHDF3 axis drives lymph node metastasis in cervical cancer via FASN translation.
    Mol Cancer. 2025;24:218.
    PubMed    
    Abstract available

  201. AGARWAL M, Kumar M, Dahiya S, Kumar A, et al
    "In silico analysis of human TLR3 missense single nucleotide polymorphisms and their potential association with cancer".
    Sci Rep. 2025;15:30837.
    PubMed    
    Abstract available

  202. FANG J, Cheng Y, Liu Y, Yang Q, et al
    How delays in seeking medical care for cervical cancer patients are affected by their health-seeking behaviour: a qualitative study.
    BMC Public Health. 2025;25:2881.
    PubMed    
    Abstract available

  203. PHUNG MT, An PL, Khoja L, Lee AW, et al
    Southern Vietnamese women's views on HPV vaccination, cervical cancer screening, and HPV self-sampling.
    Sci Rep. 2025;15:30928.
    PubMed    
    Abstract available

  204. KAZOBA F, Sauli E, Nyanza E, Amasi AI, et al
    Evaluation of variability in applicator position and organs at risk dose in fractionated intracavitary brachytherapy for cervical cancer.
    Brachytherapy. 2025 Aug 21:S1538-4721(25)00254.
    PubMed    
    Abstract available

  205. YOSHIDA M, Nunomura H, Furuta A, Yamada K, et al
    SQSTM1/p62 drives radiosensitivity in cervical cancer via autophagy-independent mechanisms.
    J Reprod Immunol. 2025;171:104633.
    PubMed    
    Abstract available

  206. ZHANG S, Wang L, Xu SY, Zhang YY, et al
    Role of indoleamine 2,3-Dioxygenase 1 in modulating the malignant biological behavior of cervical cancer cells through the Tryptophan-Kynurenine pathway.
    J Mol Histol. 2025;56:276.
    PubMed    
    Abstract available

  207. CHANDRA S, Patel M, Shah K, Trivedi K, et al
    HPV-DNA testing from self-sampled menstrual blood using M-strip: A proof-of-concept study on feasibility & acceptance of a novel biosampling method.
    Indian J Med Res. 2025;161:532-539.
    PubMed    
    Abstract available

  208. OKUMA K, Kiyomatsu T, Takiyama H, Yoshiba A, et al
    Technical report on the first clinical use of a bioabsorbable PGA spacer in HDR brachytherapy for recurrent cervical cancer.
    J Radiat Res. 2025 Aug 22:rraf053. doi: 10.1093.
    PubMed    
    Abstract available

  209. WANG CC, Barber EL
    Nodal surgery in early-stage cervical cancer: the PHENIX trial and the road ahead.
    J Gynecol Oncol. 2025 Aug 18. doi: 10.3802/jgo.2025.
    PubMed    


  210. KAJIKAWA T, Masui K, Sakai K, Takenaka T, et al
    A machine learning-based decision support tool for standardizing intracavitary versus interstitial brachytherapy technique selection in high-dose-rate cervical cancer.
    Brachytherapy. 2025 Aug 20:S1538-4721(25)00255.
    PubMed    
    Abstract available

  211. KILICOGLU GS, Azak C, Olgun M, Olcay GK, et al
    Treatment outcomes and bone health implications in younger and older patients with locally advanced cervical cancer.
    J Geriatr Oncol. 2025;16:102342.
    PubMed    


  212. NING L, Li X, Xu Y, Zhang Y, et al
    Development of a multi-indicator risk prediction model for cervical cancer associated with benzo[a]pyrene and nicotine exposure: A multi-omics study integrating toxicological analyses and molecular docking.
    Ecotoxicol Environ Saf. 2025;303:118895.
    PubMed    
    Abstract available

  213. ZHU L, Wang Y, Yang S, Li Q, et al
    Patient willingness to pay and preference for cervical cancer treatments among middle- and low-income populations in Xinjiang.
    J Patient Rep Outcomes. 2025;9:107.
    PubMed    
    Abstract available

  214. HUANG S, Guo H, Yu T, Gu G, et al
    Clinical efficacy comparison of CO2 laser treatment and LEEP surgery for cervical intraepithelial neoplasia with high-risk HPV infection.
    Afr Health Sci. 2025;25:52-58.
    PubMed    
    Abstract available

  215. ALI HAJI A, Ndaboine E, Likonda B, Ottoman O, et al
    Clinical profile and immediate outcomes of concurrent chemoradiation for cervical cancer at the Bugando medical centre in Mwanza, Tanzania.
    Afr Health Sci. 2025;25:218-226.
    PubMed    
    Abstract available

  216. HAN X, Fang M, Tan H, Wang M, et al
    Clinical Efficacy and Safety of Cadonilimab Immunotherapy in Advanced Cervical Cancer: A Retrospective Study.
    J Immunother. 2025 Aug 21. doi: 10.1097/CJI.0000000000000574.
    PubMed    
    Abstract available

  217. LIANG Y, Yang J, Wei S, Liu Y, et al
    Criteria-calibration approaches to deep learning-based cervical cancer radiation treatment auto-planning.
    Radiat Oncol. 2025;20:131.
    PubMed    
    Abstract available

  218. NAKHARUTAI N, Chitapanarux I, Tharavichitkul E, Traisathit P, et al
    Impact of PM2.5 exposure on acute toxicities and survival outcomes in radiotherapy for cervical cancer.
    Sci Rep. 2025;15:30557.
    PubMed    
    Abstract available

  219. S AN
    Letter to the Editor Regarding the Article 'Feasibility Study of an Efficient Plan Pool Adaptive Radiotherapy Technology Based on Low-dose Computed Tomography for Cervical Cancer'.
    Clin Oncol (R Coll Radiol). 2025;46:103919.
    PubMed    


  220. CUSTODIO NG, Queiroz FR, Melo Neto AB, Cavalcante BM, et al
    Membrane transporter genes predict chemoradiotherapy response in patients with cervical cancer.
    Einstein (Sao Paulo). 2025;23:eAO1154.
    PubMed    
    Abstract available

  221. YAN W, Ding B, Yu B, Jin H, et al
    The Multiomics Landscape of Plasma-Derived Small Extracellular Vesicles during the Development of HPV(+) Cervical Cancer.
    J Proteome Res. 2025 Aug 20. doi: 10.1021/acs.jproteome.5c00304.
    PubMed    
    Abstract available

  222. ALVAREZ-RODRIGUEZ S, Farinas Cabrero MA, Blanco Gonzalez JM, Fernandez-Feito A, et al
    [Readability, comprehensibility and acceptability of the materials of the Cervical Cancer Population Screening Program in Asturias: a mixed methodology study].
    Rev Esp Salud Publica. 2025;99:e202507040.
    PubMed    
    Abstract available

  223. SAEED NK, Alshaikh S, Al-Beltagi M
    Comparative study of pap smear and polymerase chain reaction tests for human papillomavirus screening in Bahrain.
    East Mediterr Health J. 2025;31:453-462.
    PubMed    
    Abstract available

  224. WANG Q, Zhang C, Liu S, Li W, et al
    Role of NTRK Fusion Genes in the Tumor Immune Microenvironment of HPV (+/-) Cervical Cancer.
    J Med Virol. 2025;97:e70564.
    PubMed    
    Abstract available

  225. PEREMIQUEL-TRILLAS P, Roura E, Rangel-Sarmiento V, Morey F, et al
    Building the foundations for an organized population-based cervical cancer screening program with primary HPV self-sampling in Catalonia, Spain: findings from a pilot implementation study.
    Front Med (Lausanne). 2025;12:1580665.
    PubMed    
    Abstract available

  226. LIU K, Zuo R, Wang Z, Chen G, et al
    IR808-ATIPA: A Dual-Function Agent for Enhanced Computed Tomography Imaging and Radiotherapy Sensitization in Cervical Cancer Treatment.
    Biomater Res. 2025;29:0222.
    PubMed    
    Abstract available

  227. FURUYA RL, Boak K, Mullen MM, Wang D, et al
    Real-world outcomes after pembrolizumab treatment for cervical cancer: Results from a university setting.
    Gynecol Oncol Rep. 2025;60:101921.
    PubMed    
    Abstract available

  228. TSEKPETSE P, Salu S, Otoo DM, Dushime JF, et al
    Rural-urban disparities in cervical cancer screening uptake and its predictors among women aged 30-49 years in Ghana: a multivariate decomposition analysis.
    BMC Womens Health. 2025;25:396.
    PubMed    
    Abstract available

  229. ENDALE HT, Negash HK, Getnet M, Asefa T, et al
    Cervical cancer screening uptake in East Africa: a systematic review and meta-analysis of observational studies.
    BMC Public Health. 2025;25:2831.
    PubMed    
    Abstract available

  230. NOVAK EN, Ma A, Kundrod KA, Chang MM, et al
    Extraction-free RT-RPA assay for detection of HPV16, HPV18, and HPV45 mRNA expression.
    Sci Rep. 2025;15:30450.
    PubMed    
    Abstract available

  231. COLLING AM, Saunders T, Creagh N, Ashfaq M, et al
    'Why Didn't I Get That Choice?': A Qualitative Exploration of How Cervical Screening Choices Are Understood and Experienced by Screen-Eligible People in Australia, Two Years After Self-Collection Became an Option for All.
    Health Expect. 2025;28:e70397.
    PubMed    
    Abstract available

  232. DRAGHINI L, Costantini S, Ippolito E, De Felice F, et al
    Potential prognostic role of the (18)F-FDG PET/CT metabolic response in locally advanced cervical cancer after definitive chemoradiotherapy: a narrative review.
    Strahlenther Onkol. 2025 Aug 19. doi: 10.1007/s00066-025-02452.
    PubMed    
    Abstract available

  233. CAMPSON A, Ernst K, Lewis K, Starr A, et al
    The role of community health workers (CHWs) in improving cervical cancer screening rates and access to treatment in underserved US populations: a scoping review.
    Cancer Causes Control. 2025 Aug 18. doi: 10.1007/s10552-025-02047.
    PubMed    
    Abstract available

  234. YUAN J, Xu N, Gong X, Ai J, et al
    Identification of neoantigen epitopes in cervical cancer by multi-omics analysis.
    Eur J Med Res. 2025;30:763.
    PubMed    
    Abstract available

  235. YANG C, Li M, Yi X, Wang L, et al
    Multiparametric MRI-based radiomics for preoperative prediction of parametrial invasion in early-stage cervical cancer.
    Front Oncol. 2025;15:1604749.
    PubMed    
    Abstract available

  236. AN X, Huang X, Yu Q, Tang Y, et al
    Bioinformatics analysis of lncRNA and mRNA differentially expressed in patients with cervical cancer.
    Front Bioinform. 2025;5:1605681.
    PubMed    
    Abstract available

  237. ZHANG Q, Chen F, Xiao Z, Li S, et al
    Self-perceived burden, fear of progression and psychological flexibility in cervical cancer survivors: A moderated network analysis.
    Asia Pac J Oncol Nurs. 2025;12:100762.
    PubMed    
    Abstract available

  238. EWAISHA R, Ruffin MT, Williams S, Chung Y, et al
    Serum profiling of the antibody response to HPV in women with or without abnormal cervical cytology undergoing cervical cancer screening.
    Front Immunol. 2025;16:1612761.
    PubMed    
    Abstract available

  239. NYAM CJ, Musa J, Joyce BT, Kim K, et al
    Molecular epidemiology of human papillomavirus genotypes among HIV-negative women and women living with HIV with cervical cancer in two regions in Nigeria.
    Int J STD AIDS. 2025 Aug 17:9564624251362592. doi: 10.1177/09564624251362592.
    PubMed    
    Abstract available

  240. HELLMAN K, Zupancic M, Jylha C, Tham E, et al
    Human Papillomavirus Type and Viral Load in Relation to Circulating Cell-Free Tumour HPV DNA Level and Survival in Cervical Cancer.
    Mol Diagn Ther. 2025 Aug 16. doi: 10.1007/s40291-025-00809.
    PubMed    
    Abstract available

  241. XU Y, Wang J, Chen G
    Analyzing the mechanism of rhubarb in the treatment of cervical cancer based on network pharmacology and molecular docking technology.
    Sci Rep. 2025;15:30027.
    PubMed    
    Abstract available

  242. YANG C, Hassan HA, Omar NF, Soo TH, et al
    The value of multi-parameters MRI based on amide proton transfer imaging in evaluating the efficacy of concurrent radiochemotherapy for locally advanced cervical cancer.
    Magn Reson Imaging. 2025;123:110507.
    PubMed    
    Abstract available

  243. ZHAO F, Zhong H, You L, Du Y, et al
    PTK6 mediated immune signatures revealed by single cell transcriptomic and multi omics big data analysis in cervical cancer.
    Discov Oncol. 2025;16:1566.
    PubMed    
    Abstract available

  244. JIAO W, Liu S, Shi J, Yu M, et al
    Integrative Genomic and Functional Approaches Identify FUOM as a Key Driver and Therapeutic Target in Cervical Cancer.
    Cancer Rep (Hoboken). 2025;8:e70306.
    PubMed    
    Abstract available

  245. LAW J, Jessiman-Perreault G, Machado AA, Xu L, et al
    Individual-level characteristics and geospatial factors associated with cervical cancer screening participation in Alberta, Canada: a population-based cross-sectional study.
    BMC Public Health. 2025;25:2790.
    PubMed    
    Abstract available

  246. VUJIC G, Planinic P, Babic I, Skvorc M, et al
    Impact of preoperative conization on treatment outcomes in cervical cancer patients undergoing abdominal radical hysterectomy.
    Bull Cancer. 2025 Aug 14:S0007-4551(25)00345.
    PubMed    
    Abstract available

  247. EZECHI OC, Akinsolu FT, Abodunrin OR, Ola OM, et al
    Implementation of Clinical Practice Guidelines to Prevent Cervical Cancer: Mixed Methods Study.
    JMIR Cancer. 2025;11:e68572.
    PubMed    
    Abstract available

  248. YODER AK, Thomas RJ, Huang A, Mandalapu A, et al
    Cervical Cancer Outcomes in Women With HIV in the Age of Antiretroviral Therapy.
    JAMA Netw Open. 2025;8:e2527389.
    PubMed    


  249. SABATINO SA, Thompson TD, Croswell JM, Villarroel MA, et al
    Use of Cancer Screening Tests, United States, 2023.
    Prev Chronic Dis. 2025;22:E52.
    PubMed    
    Abstract available

  250. BHARTI A, Hansda R, Bala R, Kumar A, et al
    To determine the diagnostic accuracy of visual inspection of cervix with acetic acid as a screening tool to detect preinvasive cervical cancer - A meta-analysis.
    J Family Med Prim Care. 2025;14:2619-2627.
    PubMed    
    Abstract available

  251. GONG Y, Zhou G, Gu Y, Zhang M, et al
    Peptostreptococcus anaerobius promotes cervical cancer angiogenesis by upregulating SCD to activate ERK pathway.
    Am J Cancer Res. 2025;15:3236-3244.
    PubMed    
    Abstract available

  252. FENG N, Liu L
    Research on the regulatory effects and mechanisms of YES1 on apoptosis and autophagy in cervical cancer cells.
    Discov Oncol. 2025;16:1555.
    PubMed    
    Abstract available

  253. GAN JW, Cao DY
    [Progress and clinical application of sentinel lymph node biopsy technique in gynecological malignant tumors].
    Zhonghua Zhong Liu Za Zhi. 2025;47:689-695.
    PubMed    
    Abstract available

  254. FENG S, Mdletshe S
    Recommendations for the use of functional medical imaging in the management of cancer of the cervix in New Zealand: a rapid review.
    N Z Med J. 2025;138:65-84.
    PubMed    
    Abstract available

  255. ZAHAN UF, Sohel HI, Nakayama K, Ishikawa M, et al
    A Comparative Analysis of Usual- and Gastric-Type Cervical Adenocarcinoma in a Japanese Population Reveals Distinct Clinicopathological and Molecular Features with Prognostic and Therapeutic Insights.
    Int J Mol Sci. 2025;26:7469.
    PubMed    
    Abstract available

  256. XU P, Uma Mageswary M, Nisaa AA, Li X, et al
    Antimicrobial and Anticancer Activities of Lactiplantibacillus plantarum Probio87 Isolated from Human Breast Milk.
    Nutrients. 2025;17:2554.
    PubMed    
    Abstract available

  257. CHEN M, Lhamo Y, Chodron K, Chen L, et al
    High-risk human papillomavirus (hr-HPV) prevalence and abnormal cervical cytology in rural high-altitude communities: a population-based cross-sectional study in the Southern Tibetan Plateau, China (2023-2024).
    Virol J. 2025;22:279.
    PubMed    
    Abstract available

  258. CATO V, Davy K, Annelies L, An N, et al
    Evaluation of a heat protocol with the Allplex HPV HR assay on the fully automated Seegene STARlet platform for detection of human papillomaviruses.
    Acta Clin Belg. 2025;80:91-99.
    PubMed    
    Abstract available

  259. XU Y, Yan X, Zhang F, Li Q, et al
    Intranasal Delivery of HPV Therapeutic Vaccines for Enhanced Mucosal Immunization and Anti-Tumor Immunity.
    ACS Nano. 2025;19:30046-30059.
    PubMed    
    Abstract available

  260. WANG Y, Li X, Lian X, Huang B, et al
    Genetic silencing of CDC6 via AAV2-Delivered shRNA as a novel cancer genetics-based therapy for cervical carcinoma.
    Cancer Genet. 2025;296-297:208-216.
    PubMed    
    Abstract available

  261. JIAN L, Wu N, Bi F, Li H, et al
    Prognosis risk stratification in patients with cervical adenocarcinoma after surgery: Development and validation of integrated biomarkers.
    Clin Radiol. 2025;88:107000.
    PubMed    
    Abstract available

  262. YAMADA R, Kawakami F, Maeda N, Nagao S, et al
    Immune cell densities, HLA status, and PD-L1 expression in stage I neuroendocrine neoplasm of the uterine cervix.
    Pathol Res Pract. 2025;273:156146.
    PubMed    
    Abstract available

  263. ZOU X, Gu T, Li X, Deng L, et al
    PAM-free activation of CRISPR/Cas12a via semi-nested asymmetric RPA: highly specific detection of HPV16 dsDNA.
    Analyst. 2025;150:3891-3898.
    PubMed    
    Abstract available

  264. CHEN Y, Li X, Chen P, Yin Z, et al
    ZNF671 methylation is a potential regression predictor of cervical intraepithelial neoplasia grade 3 in the colposcopy-to-conization interval.
    Pathol Res Pract. 2025;273:156116.
    PubMed    
    Abstract available

  265. MURUGESAN B, Rathinavel T, Kumar RS, Gomathi M, et al
    Atranorin from lichens act as potential inhibitor for cervical tumor proteins TGFbeta and kinase enzyme CDK4/CyclinD3: An anti-cancer intervention therapy.
    Int J Biol Macromol. 2025;320.
    PubMed    
    Abstract available

  266. GODOY LR, El-Zein M, Padalko E, Verberckmoes B, et al
    Comparative performance of cobas 4800 HPV Test and Anyplex II HPV HR for high-risk human papillomavirus detection.
    J Clin Microbiol. 2025 Jul 9:e0020025. doi: 10.1128/jcm.00200.
    PubMed    
    Abstract available

  267. BEN JEMIA Z, Fehri E, Ardhaoui M, Jaballah-Gabteni A, et al
    The TP53 "rs 1042522'' Polymorphism and its association with precancerous cervical lesions progression among Tunisian women.
    Diagn Microbiol Infect Dis. 2025;113:116981.
    PubMed    
    Abstract available

  268. CHAO WR, Lee MY, Lee YJ, Sheu GT, et al
    Profiling of HER2, KRAS, and PIK3CA mutations in uterine cervical neuroendocrine carcinoma and implications for oncogenic driver targeting therapy.
    Cancer Genet. 2025;296-297:9-14.
    PubMed    
    Abstract available

  269. HAMMOND KL, Kopelman ZA, Winkler SS, Buchek MC, et al
    The art of cold knife conization: a demonstration of technique in live patients and a low-fidelity simulation model.
    Am J Obstet Gynecol. 2025;233:210-214.
    PubMed    
    Abstract available

  270. TSEGAYE AT, Shing JZ, Vo JB, Kreimer AR, et al
    Racial and ethnic differences in HPV-related cancer incidence in the United States, 2001-2020.
    J Natl Cancer Inst. 2025 Apr 26:djaf107. doi: 10.1093.
    PubMed    
    Abstract available

  271. KWON SC, Kranick JA, Islam NS, Wyatt LC, et al
    Applying Social Marketing Principles for Community-Based Cancer Screening Programs: Two Case Studies.
    Health Educ Behav. 2025;52:382-391.
    PubMed    
    Abstract available

  272. SATOSKAR S, Vanderkwaak TJ, Jedrych J, Vang R, et al
    A Trichoadenoma/Trichoepithelioma/Trichoblastoma-like Lesion in the Uterine Cervix Focally Mimics an Adenoid Basal Tumor.
    Int J Gynecol Pathol. 2025;44:466-470.
    PubMed    
    Abstract available

  273. RICHTER KL, Snyman LC, Dreyer G, Van der Merwe FH, et al
    Aptima HPV E6/E7 mRNA and cytology cross-sectional performance as primary screening tests for detection of high-grade cervical lesions in HIV positive and negative women in South Africa.
    J Med Screen. 2025;32:133-140.
    PubMed    
    Abstract available

  274. LIU B, Zhang Y, Wang Q, Wang Q, et al
    CD40 ligation-induced ERK activation leads to enhanced radiosensitivity in cervical carcinoma cells via promoting autophagy.
    Acta Biochim Biophys Sin (Shanghai). 2024;57:1252-1259.
    PubMed    
    Abstract available

  275. ZYLA RE, Talia KL, Hodgson A
    Entirely Exophytic HPV-associated Endocervical Adenocarcinoma: A Rare But Potentially Aggressive Neoplastic Phenomenon.
    Int J Gynecol Pathol. 2025;44:412-418.
    PubMed    
    Abstract available

  276. HOLFORD TR, Chen HS, Kane MJ, Krapcho M, et al
    Updated CP*Trends: an online tool to compare cohort and period trends across cancer sites.
    Am J Epidemiol. 2025;194:2144-2149.
    PubMed    
    Abstract available

  277. KISAKA E, Kabalimu T, Semali I, Mashalla Y, et al
    Factors influencing utilisation of cervical cancer screening services among HIV positive women attending care and treatment centres in Kinondoni municipality, Dar es Salaam, Tanzania.
    Afr Health Sci. 2024;24:32-40.
    PubMed    
    Abstract available

  278. MACDUFFIE E, McCallister C, George J, Monare B, et al
    Assessing the impact of multidisciplinary team gynecological oncology care in Botswana: A potential model for low- and middle-income countries.
    Cancer. 2025;131:e70006.
    PubMed    
    Abstract available

  279. FAN R, Song S, Shi H, Zhang X, et al
    A Retrospective Analysis of 1151 Chinese Women With Atypical Glandular Cells: Impact of High-Risk Human Papilloma Virus Status and Age on Cervical and Endometrial Neoplasia Risk.
    Diagn Cytopathol. 2025 Jun 9. doi: 10.1002/dc.25495.
    PubMed    
    Abstract available

  280. HARDIE AN, Wenzel HHB, Schnack TH, Van der Aa MA, et al
    Oncological outcomes after radical hysterectomy followed by adjuvant (chemo)radiation or no further treatment in women with cervical cancer FIGO 2018 IB2-IIA2 - A multinational population-based cohort study.
    Eur J Cancer. 2025;227:115664.
    PubMed    
    Abstract available

  281. ZHANG Y, Kang Q, Qu R
    Letter Re: Oncological outcomes after radical hysterectomy followed by adjuvant (chemo)radiation or no further treatment in women with cervical cancer FIGO 2018 IB2-IIA2 - A multinational population-based cohort study.
    Eur J Cancer. 2025;228:115742.
    PubMed    


  282. FERREIRA MCP, Sebastiao APM, Zanine RM
    The risk of recurrence of high-grade squamous intraepithelial lesions and its association with the number of colposcopic biopsies.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114554.
    PubMed    
    Abstract available

  283. GORNIAK K, Pacholczak-Madej R, Muzykiewicz K, Blecharz P, et al
    Integrating locoregional therapy with ongoing immunotherapy after oligoprogression in recurrent/metastatic cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114658.
    PubMed    


  284. WANG Y, Jia Z, Jiao J, Yue X, et al
    Analysis of the use of prophylactic ureteral stents in preventing iatrogenic ureteral injury during radical hysterectomy for cervical Cancer.
    Gynecol Oncol. 2025;200:155-160.
    PubMed    
    Abstract available

  285. POLEN-DE CL, Giannini A, Langstraat CL, Moreno AG, et al
    Effect of conization, manipulator use, and their interaction on recurrence after radical hysterectomy for cervical cancer: A multicenter retrospective analysis.
    Gynecol Oncol. 2025;201:33-39.
    PubMed    
    Abstract available

  286. GAILLARD S, Alvarez J, Zhang T, Wang H, et al
    A randomized pilot study of HPV16 L2E7E6 fusion protein vaccination site post-treatment for HPV16+ cervical cancer.
    Gynecol Oncol. 2025;201:86-96.
    PubMed    
    Abstract available

  287. DAMGAARD R, Jenkins D, Stoler MH, van de Sandt M, et al
    p16(INK4a) and HPV E4 immunohistochemistry for the prediction of regression of cervical intraepithelial neoplasia grade 2-A historical cohort study.
    Int J Cancer. 2025 May 5. doi: 10.1002/ijc.35469.
    PubMed    
    Abstract available

  288. JENKINS M, Saidu R, Boa R, Mbatani N, et al
    Performance of thermoablation among women treated for high-risk human papillomavirus in a screen-and-treat program in South Africa.
    Int J Cancer. 2025 Jun 6. doi: 10.1002/ijc.35519.
    PubMed    
    Abstract available

  289. MORA-SOTO N, Morante-Caicedo C, Caicedo-Martinez M, Viveros-Carreno D, et al
    Morbidity of radical surgery and postoperative radiotherapy in cervical cancer.
    Int J Gynaecol Obstet. 2025 Jul 30. doi: 10.1002/ijgo.70281.
    PubMed    
    Abstract available

  290. LI Z, Wang P, Lu D, Ding Z, et al
    Development and validation of a risk prediction model for lower limb lymphedema in postoperative cervical cancer patients.
    Int J Gynaecol Obstet. 2025 Jul 30. doi: 10.1002/ijgo.70423.
    PubMed    
    Abstract available

  291. SANTIAGO SANABRIA L, Laverde Cardona VA, Perez D YR, Abreu F, et al
    Barriers in the prevention and early detection of human papillomavirus in Latin America.
    Int J Gynaecol Obstet. 2025;170:1144-1152.
    PubMed    
    Abstract available

  292. HAGEN KK, Lie AK, Dahl GF, Eyjolfsdottir B, et al
    The Silva pattern-based classification and oncological outcomes in women undergoing fertility-sparing surgery for early-stage cervical cancer.
    Int J Gynecol Cancer. 2025;35:102012.
    PubMed    
    Abstract available

  293. RISHI KS, Harshita K, Spandana P, Donapati PKR, et al
    Clinical outcomes of external radiotherapy boost versus no boost to radiologically positive lymph nodes in FIGO stage IIIC cervical cancer.
    Int J Gynecol Cancer. 2025;35:102030.
    PubMed    
    Abstract available

  294. SUZUKI DA, Gouveia MC, Bonalumi Dos Santos M, Scaranti M, et al
    Beyond survival: reclaiming quality of life after cervical cancer treatment.
    Int J Gynecol Cancer. 2025;35:102026.
    PubMed    


  295. HUANG W, Fang X, Ou X, Chen L, et al
    Postoperative Adjuvant Treatments for Cervical Cancer: A Network Meta-analysis.
    Int J Radiat Oncol Biol Phys. 2025 Jul 31:S0360-3016(25)06039.
    PubMed    
    Abstract available

  296. LI R, Sun LF, Li RZ, Wang ZY, et al
    Incidence of Vaginal Intraepithelial Neoplasia After Hysterectomy for Cervical Cancer or Cervical Intraepithelial Neoplasia: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2025 Aug 7. doi: 10.1097/AOG.0000000000006026.
    PubMed    
    Abstract available

  297. LI X, Zhou M, Yu J, Yu S, et al
    Histone modifications in cervical cancer: Epigenetic mechanisms, functions and clinical implications (Review).
    Oncol Rep. 2025;54:131.
    PubMed    
    Abstract available

  298. CORBEAU A, Astreinidou E, Kuipers SC, Wielopolski PA, et al
    Changes in bone marrow fat fraction and immune cell counts in women with cervical cancer treated with primary chemoradiotherapy.
    Radiother Oncol. 2025;211:111089.
    PubMed    
    Abstract available

  299. YAO X, Qie M, Kang L, Li M, et al
    Assessing the risk of undetected cervical cancer in women with a biopsy of high-grade cervical intraepithelial neoplasia: predictive value of cytology and endocervical curettage (ECC).
    BMC Cancer. 2025;25:1238.
    PubMed    
    Abstract available

  300. HAN S, Qin Y, He Y, Li M, et al
    LncRNA SNHG15 targets miR-200a-3p affects the proliferation, apoptosis, migration, and invasion of cervical cancer cells.
    BMC Cancer. 2025;25:1279.
    PubMed    
    Abstract available

  301. ZHANG B, Li Z, Yang Z, Yin Y, et al
    Downregulation of PGK1 promotes lipid peroxidation and suppresses proliferation in cervical cancer revealed by liquid-liquid phase separation-related gene signature.
    BMC Cancer. 2025;25:1269.
    PubMed    
    Abstract available

  302. TUPA F, Ruwaichi T, Luoga P, Mwaiselage J, et al
    Institutional management factors influencing compliance with National Cancer Treatment Guidelines for cervical cancer: a case study from ocean road cancer institute, Tanzania.
    BMC Cancer. 2025;25:1259.
    PubMed    
    Abstract available

  303. CHENG L, Xu Y, Li Z, Sun D, et al
    DHCR24 overexpression is involved in lipid metabolic reprogramming to drive cervical cancer malignant progression and is associated with immune microenvironment.
    BMC Cancer. 2025;25:1291.
    PubMed    
    Abstract available

  304. ZHANG Z, Wu H, Huang Y, Wei Y, et al
    High SNHG expression may contribute to poor cervical cancer prognosis, based on systematic reviews and meta-analyses.
    BMC Cancer. 2025;25:1350.
    PubMed    
    Abstract available

  305. MUSHUMBUSI A, Kaizilege G, Chibwe E, Ottoman O, et al
    Three-year survival outcomes following radical hysterectomy in early-stage cervical carcinoma: A study at Bugando medical centre, Mwanza, Tanzania.
    BMC Cancer. 2025;25:1343.
    PubMed    
    Abstract available

  306. LI YX, Cao SY, Fan Y, Zhang YF, et al
    Survival outcomes in IIIC cervical cancer by treatment strategies: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:1340.
    PubMed    
    Abstract available

  307. MREMA A, Ngoma M, Lugina EL, Kahakwa A, et al
    Genotype distribution of human papillomavirus among women with cervical cancer stratified by HIV status in Tanzania.
    PLoS One. 2025;20:e0322311.
    PubMed    
    Abstract available

  308. KHATRI RB, Endalamaw A, Darssan D, Assefa Y, et al
    A scoping review of the levels, implementation strategies, enablers, and barriers to cervical, breast, and colorectal cancer screening among migrant populations in selected English-speaking high-income countries.
    PLoS One. 2025;20:e0329854.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;